HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Emmanuel Mignot Selected Research

Narcolepsy

12/2015Sleep-stage transitions during polysomnographic recordings as diagnostic features of type 1 narcolepsy.
10/2015Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset.
10/2015EIF3G is associated with narcolepsy across ethnicities.
8/2015Nocturnal Sleep Dynamics Identify Narcolepsy Type 1.
7/2015Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development.
1/2015HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy.
1/2015Narcolepsy in African Americans.
1/2015HLA-DQ allele competition in narcolepsy: a comment on Tafti et al. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe.
10/2014HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency.
7/2014Retraction of the research article: "CD4⁺ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy".
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Emmanuel Mignot Research Topics

Disease

92Narcolepsy
12/2015 - 01/2002
48Cataplexy
12/2015 - 06/2002
10Disorders of Excessive Somnolence (Hypersomnia)
08/2015 - 10/2002
6Sleep Apnea Syndromes (Sleep Apnea)
06/2013 - 12/2004
5Idiopathic Hypersomnolence
08/2015 - 01/2003
5Sleep Disorders
07/2013 - 10/2002
4Sleep Deprivation
12/2015 - 01/2004
4Human Influenza (Influenza)
01/2015 - 10/2013
4Nervous System Diseases (Neurological Disorders)
10/2010 - 10/2002
4Sleep Initiation and Maintenance Disorders (Insomnia)
10/2007 - 10/2002
3Inflammation
11/2015 - 08/2006
3Infection
01/2015 - 12/2011
3Obesity
02/2013 - 12/2004
3Insulin Resistance
01/2011 - 11/2009
2Autoimmune Diseases (Autoimmune Disease)
10/2015 - 06/2013
2Disease Susceptibility (Diathesis)
01/2015 - 02/2006
2Hypertension (High Blood Pressure)
04/2007 - 12/2004
2Multiple Sclerosis
03/2007 - 01/2004
2Obstructive Sleep Apnea
02/2006 - 10/2002
2Dementia (Dementias)
12/2004 - 01/2004
2Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
06/2003 - 10/2002
1Ankylosing Spondylitis
08/2014
1Cerebellar Ataxia (Dysmetria)
05/2014
1Deafness (Deaf Mutism)
05/2014
1Precocious Puberty
02/2013
1Weight Gain
02/2013
1Overweight
02/2013
1Sleep Paralysis
09/2012
1Movement Disorders (Movement Disorder)
12/2011
1Streptococcal Infections (Streptococcal Infection)
01/2010
1Bacterial Infections (Bacterial Infection)
08/2009
1Wounds and Injuries (Trauma)
07/2008
1Fibromyalgia (Fibrositis)
04/2007
1Apnea
06/2006
1Huntington Disease (Huntington's Disease)
12/2005
1Craniopharyngioma (Craniopharyngiomas)
11/2005

Drug/Important Bio-Agent (IBA)

79orexins (orexin)IBA
12/2015 - 01/2002
12AntigensIBA
01/2015 - 01/2007
12human HLA-DQB1 proteinIBA
05/2011 - 10/2002
10NeuropeptidesIBA
12/2013 - 11/2002
6HLA-DQB1 antigen (HLA DQB1)IBA
10/2015 - 01/2013
6Sodium Oxybate (gamma Hydroxybutyrate)FDA Link
11/2010 - 11/2004
5Neurotransmitter Agents (Neurotransmitter)IBA
06/2005 - 01/2002
4HLA-DQ Antigens (HLA-DQ)IBA
01/2015 - 10/2002
4Histamine (Histamine Dihydrochloride)FDA Link
12/2013 - 11/2002
4T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2013 - 06/2009
4AutoantibodiesIBA
06/2013 - 01/2009
4HLA-DRB1 antigen (HLA DRB1)IBA
11/2008 - 01/2004
3C-Reactive ProteinIBA
11/2015 - 08/2006
3HLA-DQA1 (HLA DQA1)IBA
01/2015 - 12/2013
3Cathepsin HIBA
10/2013 - 01/2013
3modafinil (armodafinil)FDA Link
04/2012 - 07/2006
3Insulin (Novolin)FDA Link
01/2011 - 11/2009
3AntibodiesIBA
07/2010 - 08/2009
3streptolysin OIBA
07/2010 - 08/2009
3LeptinIBA
10/2007 - 01/2003
2Biological Markers (Surrogate Marker)IBA
06/2014 - 01/2003
2Influenza Vaccines (FluMist)IBA
01/2014 - 12/2013
2Apolipoproteins E (ApoE)IBA
06/2013 - 02/2006
2ApolipoproteinsIBA
06/2013 - 02/2006
2HDL CholesterolIBA
02/2013 - 11/2009
2Intravenous Immunoglobulins (IVIG)FDA Link
07/2012 - 10/2008
2Carbon MonoxideIBA
12/2011 - 12/2008
2deoxyribonuclease BIBA
01/2010 - 08/2009
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
04/2007 - 12/2004
2Antidepressive Agents (Antidepressants)IBA
02/2007 - 07/2006
2Amphetamine (Amfetamine)FDA LinkGeneric
07/2006 - 06/2005
2Dopamine (Intropin)FDA LinkGeneric
06/2004 - 11/2002
1IronIBA
11/2015
1Ferritins (Ferritin)IBA
11/2015
1CytokinesIBA
10/2015
1ChemokinesIBA
10/2015
1VaccinesIBA
07/2015
1HLA-DPB1 (HLA DPB1)IBA
01/2015
1HLA-DP Antigens (HLA-DP)IBA
01/2015
1micaIBA
08/2014
1HLA-B Antigens (HLA-B)IBA
08/2014
1DNA (Cytosine-5-)-Methyltransferase (DNA (Cytosine 5) Methyltransferase)IBA
05/2014
1EpitopesIBA
12/2013
1Proteins (Proteins, Gene)IBA
12/2013
1melanin-concentrating hormone (melanin concentrating hormone)IBA
12/2013
1DNA (Deoxyribonucleic Acid)IBA
10/2013
1A-Form DNA (A-DNA)IBA
06/2013
1Apolipoprotein E4IBA
06/2013
1OX40 LigandIBA
01/2013
1Messenger RNA (mRNA)IBA
04/2012
13' Untranslated Regions (3' UTR)IBA
01/2011
1venlafaxine (Effexor)FDA LinkGeneric
11/2010
1Protein Disulfide-IsomerasesIBA
01/2010
1Ulnar-mammary syndromeIBA
12/2009
1Glucose (Dextrose)FDA LinkGeneric
11/2009
1Immunoglobulin G (IgG)IBA
08/2009
1HLA-DR2 Antigen (HLA DR2 Antigen)IBA
06/2009
1Immunoglobulins (Immunoglobulin)IBA
10/2008
1GhrelinIBA
10/2007
1Hydrocortisone (Cortisol)FDA LinkGeneric
10/2007
1AngiotensinsIBA
04/2007
1styrene-methylmethacrylate copolymerIBA
03/2007
1oligodendrocyte-myelin glycoproteinIBA
03/2007
1OxygenIBA
06/2006